Journal of Applied Physiology AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 94: 1186-1192, 2003. First published October 25, 2002; doi:10.1152/japplphysiol.00662.2002
8750-7587/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
94/3/1186    most recent
00662.2002v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prisk, G. K.
Right arrow Articles by Reed, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prisk, G. K.
Right arrow Articles by Reed, J. W.
Vol. 94, Issue 3, 1186-1192, March 2003

Validation of measurements of ventilation-to-perfusion ratio inequality in the lung from expired gas

G. Kim Prisk, Harold J. B. Guy, John B. West, and James W. Reed

Department of Medicine 0931, University of California, San Diego, La Jolla, California 92093


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The analysis of the gas in a single expirate has long been used to estimate the degree of ventilation-perfusion (VA/Q) inequality in the lung. To further validate this estimate, we examined three measures of VA/Q inhomogeneity calculated from a single full exhalation in nine anesthetized mongrel dogs under control conditions and after exposure to aerosolized methacholine. These measurements were then compared with arterial blood gases and with measurements of VA/Q inhomogeneity obtained using the multiple inert gas elimination technique. The slope of the instantaneous respiratory exchange ratio (R slope) vs. expired volume was poorly correlated with independent measures, probably because of the curvilinear nature of the relationship due to continuing gas exchange. When R was converted to the intrabreath VA/Q (iV/Q), the best index was the slope of iV/Q vs. volume over phase III (iV/Q slope). This was strongly correlated with independent measures, especially those relating to inhomogeneity of perfusion. The correlations for iV/Q slope and R slope considerably improved when only the first half of phase III was considered. We conclude that a useful noninvasive measurement of VA/Q inhomogeneity can be derived from the intrabreath respiratory exchange ratio.

single-breath tests; respiratory exchange ratio


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

THE ANALYSIS OF THE GAS in a single expirate has long been used to estimate the degree of inequality in the ventilation-to-perfusion ratio (VA/Q) in the lung. West and colleagues (10) showed that an index of VA/Q inequality could be obtained in the lung by calculating the change in respiratory quotient in expired gas, provided mixed venous blood gas composition was assumed to be constant during the expiration. Later, Guy et al. (3) used computerized data acquisition to allow the calculation of the intrabreath respiratory exchange ratio (R) over the course of a single vital capacity expiration. In addition, the resulting plot of intrabreath R could then be compared with the theoretical behavior of a perfectly mixed lung model to provide an index of VA/Q inhomogeneity that was less sensitive to ongoing gas exchange. As shown by West et al. (10), proportional changes in respiratory quotient could be converted to proportional changes in VA/Q without knowledge of the exact mixed venous blood composition if this remained the same.

The technique has been applied to provide an index of the range of VA/Q in the lung. For example, Prisk et al. (5) used this technique to measure the range of VA/Q in subjects exposed to periods of weightlessness during spaceflight in Spacelab, and at the present time this technique is also in use on the International Space Station. Recently, Cremona et al. (1) used plots of intrabreath R to determine closing volume in subjects who may have high-altitude pulmonary edema, but they did not extend the measurements to determination of the range of VA/Q in these subjects.

However, despite occasional use, the technique has never been validated against other known techniques for measuring VA/Q inequality in the lung. We provide the first such validation by measuring the intrabreath VA/Q range (iV/Q) in anesthetized dogs under normal conditions and after the inhalation of methacholine. The noninvasive measurements of intrabreath R and iV/Q, which are comparable to the previous method of West et al. (10), are compared with the range of VA/Q in the same animals determined using arterial blood gases and also the multiple inert gas elimination technique (MIGET).


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Experimental details. The study was approved by the University of California, San Diego, Animal Subjects Committee. Nine mongrel dogs [18-24 (mean 20.6) kg body wt] were anesthetized with pentobarbital sodium (30 mg/kg iv) and paralyzed with pancuronium bromide (0.1 mg/kg iv). The level of anesthesia and relaxation was maintained by incremental administration of both drugs. A cuffed endotracheal tube (9 mm ID) was placed through a tracheostomy. Normal arterial blood gas tensions were maintained by adjusting the frequency of a Harvard mechanical ventilator set at a tidal volume of 15 ml/kg. A 7-Fr Swan-Ganz catheter was inserted via the right external jugular vein and advanced into the pulmonary artery by using direct pressure monitoring. The femoral artery was cannulated for sampling arterial blood (Fig. 1).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 1.   Experimental design allowing constant inspiratory and expiratory flow rates during single-breath respiratory exchange ratio tests. System is adapted from that of Tomioka et al. (7). Animal was ventilated normally using the respirator and then connected to the +80-cmH2O air source via a throttling valve. This resulted in an inspiration to maximum lung volume at ~0.1 l/s. Then the animal was switched to the -80-cmH2O air source and deflated at ~0.1 l/s to minimum lung volume. Paw, airway pressure; Pfa, femoral arterial pressure; A/D, analog-to-digital converter.

Flow through the endotracheal tube was measured with a pneumotachograph (Fleisch no. 1) connected to a differential pressure transducer (Validyne MP-45). Before each study, the flowmeter was calibrated using a 1-liter precision syringe.

Gas concentrations were measured using a mass spectrometer (model MGA-1100, Perkin-Elmer) sampling from the midstream point of the proximal end of the endotracheal tube. The sample transit time was checked each day and was generally ~400 ms. This was later used to correctly align the gas concentration and flow signals before analysis. Airway pressure was measured via a Statham P23 ID transducer connected to a point 8 cm distal to the mass spectrometer sampling point. This position was selected to avoid sampling puffs of gas from the airway pressure catheter during major pressure changes.

Data were monitored on a strip-chart recorder (Gould-Brush Mark 200) and digitized at 30 Hz using a 12-bit analog-to-digital converter in a computer system.

Methacholine administration. We used aerosolized methacholine to induce bronchoconstriction and, thus, alter the distribution of ventilation. A 1% methacholine solution was aerosolized using a jet nebulizer (Acorn II, Marquest Medical Products) and administered via the ventilator circuit for 1 min. During this time, the respiratory rate was adjusted to maintain a normal end-tidal CO2. A short period was then allowed to obtain a new quasi-steady state, and the measurements after methacholine administration were performed. On average, postmethacholine measurements were made ~27 min after methacholine administration.

MIGET. MIGET was applied as described by Gale et al. (2). The inert gas solution (SF6, ethane, cyclopropane, enflurane, ether, and acetone) was prepared in 5% dextrose (2) and infused for ~20 min at ~10 ml/min before collection of the samples. The total volume of fluid infused over the course of the study (1-2 h) was ~1 liter.

Quadruplicate 15-ml samples of mixed expired gas and duplicate 6-ml samples of pulmonary and systemic arterial blood were obtained using gastight syringes under normal conditions (before the iV/Q measurements) and after the stabilization subsequent to methacholine administration (just before the iV/Q measurements). These samples were used to measure the steady-state concentrations of the six inert gases using a gas chromatograph (model 5890A, Hewlett-Packard, Wilmington, DE) (9). VA/Q distributions were calculated by using MIGET in the usual fashion. Solubilities, retentions (the ratio of arterial to mixed venous partial pressures), and excretions (the ratio of mixed expired to mixed venous partial pressure) for the inert gases were determined and corrected for body temperature, and VA/Q distributions were calculated from the inert gas data (8, 9). The second moment of the perfusion distribution exclusive of intrapulmonary shunt (SDQ) and the second moment of the ventilation distribution exclusive of dead space (SDV) were used as indicators of the degree of VA/Q inequality. Dispersion of retention (DispR), excretion (DispE), and retention minus excretion (Disp- E) were derived directly from the retention and excretion data (2). The residual sum of squares was used as an indicator of the adequacy of fit of the data to the 50-compartment model of the lung (9).

Blood gas measurements. Arterial samples (2 ml) were collected immediately after each inert gas sample and kept on ice until analyzed for PO2, PCO2, and pH using a blood gas analyzer (model IL-1306, Instrumentation Laboratories, Lexington, MA). Alveolar-arterial PO2 difference was determined using the ideal alveolar PO2 calculated using the alveolar gas equation and measured arterial PCO2 (PaCO2) and R.

iV/Q test maneuver. For each test, the dogs were ventilated at a constant rate and tidal volume until stable end-tidal gas concentrations were obtained. Data were then collected for >= 60 s to provide a measurement of O2 consumption and CO2 production. The technique described by Tomioka et al. (7) was used. At the end of a normal expiration, the airway was connected to a constant-pressure source of air at +80 cmH2O pressure, and the animal was inflated to full lung volume. Inflation was via a flow restrictor limiting flow to ~0.1 l/s. On reaching maximum volume, the airway was connected to a constant-pressure source of -80 cmH2O and deflated (again via the flow restrictor at ~0.1 l/s) to minimum lung volume. The animal was then returned to normal ventilation.

iV/Q analysis. The slow vital capacity expiration was analyzed using the techniques described by Guy et al. (3). Gas concentration data were converted on a point-by-point basis to R using the standard alveolar gas equation (3)
R = <FR><NU>P<SC>e</SC><SUB>CO<SUB>2</SUB></SUB></NU><DE>P<SC>i</SC><SUB>O<SUB>2</SUB></SUB>∗(P<SC>e</SC><SUB>N<SUB>2</SUB></SUB>/P<SC>i</SC><SUB>N<SUB>2</SUB></SUB>) − P<SC>e</SC><SUB>O<SUB>2</SUB></SUB></DE></FR>
where PECO2 is expired PCO2, PEO2 and PIO2 are expired and inspired PO2, and PEN2 and PIN2 are expired and inspired PN2. The data were then plotted as a function of expired volume (Fig. 2). Because a perfectly homogeneous lung produces intrabreath R curves that are curvilinear as a result of continuing gas exchange (4), it is difficult to separately determine the change in R caused by VA/Q inequality.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2.   Respiratory exchange ratio (R) plotted as a function of expired volume in a dog in the control state (thin trace). Dashed curves represent output from the model with ventilation-to-perfusion ratios (VA/Q) differing by 20% from that of the center dashed curve. VA/Q values corresponding to each model line are indicated. Thick trace, plot of intrabreath VA/Q (iV/Q) obtained by interpolating the R line on the basis of the 3 R model lines. In R and iV/Q data, cardiogenic oscillations and a terminal rise (phase IV) can be clearly seen. Note curvilinear behavior of the R isopleths, which results from continuing gas exchange. It is this curvilinear behavior that makes interpretation of the R data against volume difficult.

For this reason, the behavior of a theoretical lung performing the same controlled vital capacity expiration was calculated. The model comprises a single, perfectly mixed compartment connected via a serial dead space to the mouth and supplied with blood of constant mixed venous concentration at a constant cardiac output (Q). Appropriate choices for residual volume, Q, lung tissue volume and ventilation, and gas exchange from the preceding period of quiet breathing are made (3). Errors made in the choice of these variables have only modest effects on the output. For example, a large (10 Torr) error in the mixed venous PCO2 results in only a 5% error in the resulting variation in VA/Q (3).

On the basis of these initial conditions, the mixed venous and alveolar points corresponding to that VA/Q are calculated using the Kelman routines (11). The model then calculates the instantaneous R as a function of expired volume for the same volume history as the animal. To produce a family of R isopleths, the simulation is repeated varying Q (and, therefore, VA/Q) from its initial estimate in 10% steps up and down. These R isopleths form a scale for VA/Q, inasmuch as each individual isopleth describes the behavior of a lung, free of VA/Q inequality, following the same lung volume history as the animal.

In this way, the measured R curve is transformed to an iV/Q curve by calculating the point-by-point iV/Q from linear interpolation between the family of R isopleths calculated for different VA/Q values. This has the advantage of providing straight-horizontal isopleths of iV/Q vs. expired volume as opposed to the curvilinear R isopleths. Figure 2 shows a sample intrabreath R curve, the isopleths of VA/Q, and the resultant iV/Q curve.

From the plot of iV/Q as a function of expired volume (Fig. 3), we identified the onset of phase IV (airway closure) and measured the slope of the curve using linear least-squares regression as a function of expired volume (iV/Q slope). We determined the range of iV/Q (iV/Q range) by measuring the maximum differences in iV/Q over the portion of the exhalation corresponding to phase III. Thus iV/Q range included any excursions in iV/Q beyond that of slope itself caused by cardiogenic oscillations and by any deviation from the least-squares fitted line. Figure 3 illustrates these parameters. Additionally, using the intrabreath R curve (Fig. 2), we measured the slope of R as a function of expired volume (R slope) over the same lung volume range and also used this as a possible index of inhomogeneity of gas exchange, reasoning that, although the isopleths were curvilinear, an index based on this curve alone would be easier to calculate than the iV/Q-based measurements.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3.   Plot of iV/Q as a function of volume (data from Fig. 2). Dashed vertical lines, limits of phase III. Note abrupt rise in iV/Q at onset of phase IV. iV/Q slope as fitted between these limits is indicated by the thick line. iV/Q slope calculated over first and second halves of phase III are also shown (thin line). Solid vertical bar, iV/Q range over phase III.

Statistical techniques. Values are means ± SE. Two-way ANOVA was performed on the results where appropriate, and in cases with significant F ratios, post hoc pairwise comparisons were made using the Bonferroni adjustment (Systat version 5). To compare responses, linear regression was used (Excel 2002, Microsoft, Redmond, WA). Significance was accepted at P < 0.05.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Gas exchange. During control measurements performed before methacholine administration, arterial blood gases were essentially normal, with PaCO2 of 34.5 Torr and arterial PO2 (PaO2) of 87 Torr (inspired O2 fraction = 0.21 in all cases). Methacholine administration worsened gas exchange: PaCO2 of 36.2 Torr and PaO2 of 63 Torr (Table 1). Alveolar-arterial PO2 difference increased from 23 to 40 Torr after methacholine administration. Table 1 lists the average values for the gas exchange variables and other measurements for the control period and after methacholine administration.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Gas exchange, inert gases, and iV/Q

Multiple inert gas variables. Methacholine administration resulted in a significant widening of the VA/Q distribution (Table 1), with SDQ increasing from 0.64 to 1.33 (Fig. 4). There were comparable increases in DispR, DispE, and Disp- E.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 4.   Sample distributions of ventilation (V) and perfusion (Q) as a function of VA/Q before (A) and after (B) methacholine administration. Data were obtained using the multiple inert gas elimination technique (MIGET). Methacholine administration resulted in a significant widening of distribution of perfusion. Presence of ventilation at high VA/Q is commonly seen with mechanical ventilation.

Expired gas variables. Neither iV/Q range nor R slope changed significantly as a result of methacholine administration (Table 1). iV/Q slope became steeper (more negative) as a result of methacholine administration, changing from -0.092 ± 0.021 to -0.245 ± 0.089 (P < 0.10; cf. Fig. 3 with Fig. 5).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5.   Plot of iV/Q as a function of volume (thick trace) and intrabreath R (thin trace) in the same dog used in Figs. 2 and 3 after exposure to methacholine. Note significantly different behavior between the first and second half of phase III for iV/Q that is not apparent in R. Lines for calculated phase III slopes and range are shown only for iV/Q for reasons of clarity; format as in Fig. 3.

Because there were often significant nonlinearities in the plot of R as a function of volume and iV/Q as a function of volume, we then considered R slope and iV/Q slope over the first and second halves of phase III by dividing that portion of the exhalation into two halves and repeating the slope measurements (Fig. 5). When the breath divided into the first and second halves of phase III was considered, the effect of methacholine on iV/Q slope was much greater over the first than over the second half of the breath. Over the first half of phase III, iV/Q slope significantly steepened from -0.020 ± 0.025 to -0.379 ± 0.108 (P < 0.05); over the second half of the breath, iV/Q slope changed from -0.149 ± 0.034 to -0.122 ± 0.076 (not significant). In contrast, R slope over the first half of the exhalation became considerably steeper after methacholine administration (-0.014 ± 0.017 vs. -0.190 ± 0.033, P < 0.05), but R slope over the second half of the breath was considerably flatter after exposure to methacholine (-0.325 ± 0.061 vs. -0.180 ± 0.028, P < 0.05). The major changes are shown in Fig. 6.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 6.   Indexes of VA/Q inequality and gas exchange before (open bars) and after (solid bars) methacholine administration. PaO2, arterial PO2; AaDO2, alveolar-arterial PO2 difference; SDQ, log SD of perfusion (multiplied by 100 for display purposes); iV/Q slope, slope of iV/Q plot vs. volume over phase III (multiplied by -1,000 for display purposes); 1st and 2nd iV/Q, iV/Q slope over first and second halves of phase III; R, slope of R plot vs. volume over phase III (multiplied by -1,000 for display purposes); 1st and 2nd R, R slope over first and second halves of phase III. * P < 0.05; (*) P < 0.10 compared with control.

Correlations between intrabreath R, iV/Q, and other measures of gas exchange. iV/Q slope correlated strongly with several measures of gas exchange and VA/Q distribution. Table 2 lists the correlation coefficients between iV/Q and blood gas and inert gas variables. iV/Q slope was most strongly correlated with blood gases and with the indexes of MIGET associated with pulmonary perfusion, DispR and SDQ.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Significant correlation coefficients

Not surprisingly, iV/Q slope over the first half of the breath correlates strongly with iV/Q slope over the entire breath (r2 = 0.85, P < 0.05). However, iV/Q slope over the first half of the breath is much less strongly correlated with iV/Q slope over the second half of the breath (r2 = 0.28), supporting the observation of significant nonlinearities in iV/Q slope. The change in iV/Q slope over the first half of phase III was the most strongly correlated with all other variables measured in these dogs, showing significant correlations with all measures of VA/Q inhomogeneity, with the exception of SDV. Correlations with iV/Q slope over the second half of the breath were much weaker (Table 2).

Similarly, R slope over the first half of phase III was strongly correlated with other measures of gas exchange. In general, R slope over the first half of the breath correlated with the same variables as did iV/Q slope over the first half of the breath, and the correlations were of similar strength (Table 2). As was the case with iV/Q slope, R slope over the second half of the breath was poorly correlated with other measures of gas exchange.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

iV/Q slope. The correlations between iV/Q slope and independent measures of VA/Q inhomogeneity before and after methacholine administration (Table 2) suggest that iV/Q slope provides a useful index of gas exchange disruption. In particular, in this circumstance, it appears that the administration of aerosolized methacholine resulted in different behavior of the lung when the gas expired from the lung in the first half of the breath was compared with the gas expired from the lung in the second half of the breath. When we considered iV/Q slope calculated from only the first half of the exhalation, we obtained better correlations with independent measures of VA/Q inhomogeneity (Table 2). Although calculation of iV/Q slope is somewhat complex, iV/Q slope has the advantage of being a completely noninvasive measurement and relatively simple to perform experimentally.

Necessary assumptions in the calculation of iV/Q are the concentrations of O2 and CO2 in the mixed venous blood entering the lungs. We used an estimate of these based on O2 consumption, CO2 production, and assumed Q (the Fick principle). West et al. (10) showed that although the value of iV/Q corresponding to a particular value of R is sensitive to the composition of the mixed venous blood, the fractional change in calculated iV/Q is very insensitive. Errors in O2 and CO2 concentration in opposite directions (such as those arising from an error in metabolic rate or Q) result in very small errors in iV/Q. A 10% error of this nature results in changes in iV/Q of <1%, which, when coupled with the previous observations of West et al., shows that conversion from R to iV/Q is robust.

Effect of methacholine. We used methacholine to induce bronchoconstriction and, presumably, uneven ventilation, thus disrupting gas exchange. We wished to induce gas exchange lesions of varying intensity to test the usefulness of the change in iV/Q slope over a range of gas exchange defect severity. PaO2 was between 93 and 44 Torr (between 93 and 69 Torr for control condition and between 83 and 44 Torr after methacholine), which shows that we were successful in inducing a range of severity of the gas exchange defect between different animals. Similarly, calculated alveolar-arterial PO2 difference rose from 23 to 40 Torr after methacholine administration. That iV/Q slope (and especially iV/Q slope over the first half of the exhalation) correlates well with the change in PaO2 and with alveolar-arterial PO2 difference (Table 2) is a good indication that the measurement is a useful noninvasive means by which to determine the severity of a gas exchange defect. The change in the distribution of VA/Q distributions from MIGET (Fig. 4) is similar to that reported in previous studies. In particular, an increase in the inhomogeneity of ventilation resulting from bronchoconstriction in dogs results in a widening of the distribution of perfusion (an increase in SDQ) through the appearance of a low VA/Q mode (6).

Intrabreath changes in iV/Q. There were significant differences in iV/Q slope measured over the first and second halves of phase III of the vital capacity expiration, in particular, in those tests after methacholine administration (Table 1). Although it might be tempting to compare the first and second halves of the breath, such a comparison is almost certainly invalid when attempting to compare the data before and after methacholine administration. Although after methacholine administration the portion of the lung that empties first exhibits a greater degree of VA/Q inhomogeneity than does the portion that empties last, there is no means to determine whether these correspond to the same lung regions measured before methacholine administration.

To investigate the degree of VA/Q inequality in the entire lung, it is important to consider data only from phase III. The onset of phase IV represents the point at which airway closure occurs somewhere in the lung. Thus, after that point, exhaled gas is a reflection of only those regions still contributing to the exhalate. However, it is not generally possible to determine which lung regions close, especially in abnormal lungs, such as those exposed to methacholine. Although the iV/Q data from phase IV may provide insight into other aspects of VA/Q inhomogeneity, they are likely not useful in comparing iV/Q with whole lung measures such as MIGET.

It is important to recognize that the model used to generate the R isopleths, from which iV/Q is calculated, is not intended to represent an actual lung. Rather, it is used to provide a series of reference lines describing how a perfect lung, following the same lung volume history as the test lung, would behave. The data from the test lung are then interpreted using this scale "as if" the test lung were a collection of such perfect lungs following the same volume history. Although the gas arising from a particular lung unit with a given VA/Q may well have significant phase III slopes of O2 and CO2, there is no corresponding effect on the phase III slope for R (and, hence, for iV/Q). This is because, on the O2-CO2 diagram, the value of R is the slope of the line joining the inspired point and the alveolar point. Thus any factor that contributes to variable mixtures from these sources produces no change in R (the obvious example being the lack of effect of dead space admixture, which has a big effect on the O2 and CO2 trace, especially in the first half of expiration). Thus, with changes in R (and iV/Q), we are measuring the effects of different lung regions with different VA/Q ratios emptying at different points in the breath. The causes of such differences in emptying cannot be inferred from these measurements. However, it is clear from these data, and from those of West et al. (10) and Guy et al. (3), that the patterns that result are strikingly different between normal and abnormal lungs.

Using R slope instead of iV/Q slope. We also attempted to determine whether the slope of the R plot vs. expired volume (R slope) could be used instead of the computationally more demanding iV/Q plot. As the data in Table 2 illustrate, there were virtually no significant correlations between R slope and the independent measures of VA/Q inhomogeneity, nor did R slope change as a result of methacholine administration (Table 1). We were not entirely surprised by this finding. As Fig. 2 illustrates, even a perfectly mixed lung (the model lines in Fig. 2) produces curvilinear R plots. Attempting to measure a slope from a curvilinear plot such as that shown in Fig. 2 introduces considerable error into the resulting slope unrelated to a VA/Q defect. This is reflected in the poor correlation performance (Table 2).

R slope over the first half of phase III produced correlations with independent measures of gas exchange that were almost as strong as those from iV/Q slope measured over the first half of phase III. This measurement may provide a more easily calculated surrogate to iV/Q slope, albeit at the expense of not having a scale that is as easily interpretable. The degree of curvilinearity [which results from continuing gas exchange as the exhalation proceeds (3, 4)] depends largely on lung volume and expired flow rate, with smaller lung volumes and lower flow rates exhibiting greater curvilinearity. These effects are smallest over the first half of phase III. Thus measurements of R slope over the first half of phase III in adult humans in which exhalation is kept to less than ~10 s may be less prone to the curvature artifact. In that case, a stronger correlation between the independent measures of VA/Q inhomogeneity and R slope might result.

Other expired gas measurements of VA/Q inhomogeneity. The most informative expired gas measurements of VA/Q inhomogeneity in this study were iV/Q slope and R slope over the first half of phase III. We attempted to use the range of iV/Q, which also includes any contribution from cardiogenic oscillations. It might be expected that the magnitude of the cardiogenic oscillations would be an indicator of the range of VA/Q inhomogeneity in the lung. If this is the case, then it might be thought that including this component in the measurement by measuring the range (as opposed to the slope, which averages out any component due to cardiogenic oscillations) would improve the noninvasive estimation of VA/Q inhomogeneity. However, on the basis of the much less robust correlations in Table 2, this appears not to be the case.

In conclusion, in anesthetized dogs exposed to methacholine, measurements of iV/Q slope provide a useful index of the degree of VA/Q disruption in the lung. The changes in iV/Q slope correlate well with more direct measurements of VA/Q range obtained using MIGET and also with changes in arterial blood gas variables. The degree of correlation is improved when only gas from the first half of exhalation is considered. Because iV/Q slope can readily be measured noninvasively, this may prove useful in future studies of disruption to gas exchange, especially in humans in remote environments where noninvasive techniques are often desirable.


    ACKNOWLEDGEMENTS

We acknowledge the excellent technical support of Jane Lindsay and Frank Lopez and thank Peter Wagner for useful discussions relating to these studies.


    FOOTNOTES

This work was supported in part by National Aeronautics and Space Administration Contract NAS9-98124.

Present address of J. W. Reed: Dept. of Physiological Sciences, University of Newcastle Upon Tyne, Newcastle Upon Tyne, UK.

Address for reprint requests and other correspondence: G. K. Prisk, Dept. of Medicine, 0931, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0931 (E-mail: kprisk{at}ucsd.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

First published October 25, 2002;10.1152/japplphysiol.00662.2002

Received 19 July 2002; accepted in final form 14 October 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Cremona, G, Asnaghi R, Baderna P, Brunetto A, Brutsaert T, Cavallaro C, Clark TM, Cogo A, Donis R, Lanfranchi P, Luks A, Novello N, Panzetta S, Perini L, Putnam M, Spagnolatti L, Wagner H, and Wagner PD. Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study. Lancet 359: 303-309, 2002[Web of Science][Medline].

2.   Gale, GE, Torre-Bueno JR, Moon RE, Saltzman HA, and Wagner PD. Ventilation-perfusion inequality in normal humans during exercise at sea level and simulated altitude. J Appl Physiol 58: 978-988, 1985[Abstract/Free Full Text].

3.   Guy, HJ, Gaines RA, Hill PM, Wagner PD, and West JB. Computerized noninvasive tests of lung function. A flexible approach using mass spectrometry. Am Rev Respir Dis 113: 737-744, 1976[Web of Science][Medline].

4.   Meade, F, Pearl N, and Saunders MJ. Distribution of lung function (VA/Q) in normal subjects deduced from changes in alveolar gas tensions during expiration. Scand J Respir Dis 48: 354-365, 1967.

5.   Prisk, GK, Elliott AR, Guy HJB, Kosonen JM, and West JB. Pulmonary gas exchange and its determinants during sustained microgravity on Spacelabs SLS-1 and SLS-2. J Appl Physiol 79: 1290-1298, 1995[Abstract/Free Full Text].

6.   Rubinfeld, AR, Wagner PD, and West JB. Gas exchange during acute experimental canine asthma. Am Rev Respir Dis 118: 525-536, 1978[Medline].

7.   Tomioka, S, Kubo S, Guy HJB, and Prisk GK. Gravitational independence of single-breath washout tests in recumbent dogs. J Appl Physiol 64: 642-648, 1988[Abstract/Free Full Text].

8.   Wagner, PD, Naumann PF, and Laravuso RB. Simultaneous measurement of eight foreign gases in blood by gas chromatography. J Appl Physiol 36: 600-605, 1974[Free Full Text].

9.   Wagner, PD, Saltzman HA, and West JB. Measurement of continuous distributions of ventilation-perfusion ratios: theory. J Appl Physiol 36: 588-599, 1974[Free Full Text].

10.   West, JB, Fowler KT, Hugh-Jones P, and O'Donnell TV. Measurement of the ventilation-perfusion ratio inequality in the lung by the analysis of a single expirate. Clin Sci 16: 529-547, 1957[Web of Science][Medline].

11.   West, JB, and Wagner PD. Pulmonary gas exchange. In: Bioengineering Aspects of the Lung, edited by West JB.. New York: Dekker, 1977, p. 361-457. (Lung Biol. Health Dis. Ser.)


J APPL PHYSIOL 94(3):1186-1192
8750-7587/03 $5.00 Copyright © 2003 the American Physiological Society



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
G. K. Prisk, J. M. Fine, T. K. Cooper, and J. B. West
Vital capacity, respiratory muscle strength, and pulmonary gas exchange during long-duration exposure to microgravity
J Appl Physiol, August 1, 2006; 101(2): 439 - 447.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. K. Prisk, J. M. Fine, T. K. Cooper, and J. B. West
Pulmonary gas exchange is not impaired 24 h after extravehicular activity
J Appl Physiol, December 1, 2005; 99(6): 2233 - 2238.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
94/3/1186    most recent
00662.2002v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prisk, G. K.
Right arrow Articles by Reed, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prisk, G. K.
Right arrow Articles by Reed, J. W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online